Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer Completed surveys were obtained from 685 (86%) of 797 ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

No significant differences observed in standard oncologic outcomes and quality of life at 12 weeks. Robot-assisted laparoscopic prostatectomy (RALP) results in similar functional outcomes at 12 weeks ...

Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...

A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...

Led by Prof Santosh Kumar, the urology team at Chandigarh’s PGIMER completes a marathon session of four robotic radical ...

A TURBT allows examination beyond the bladder. Study findings support attempting nerve-sparing surgery in patients with confirmed high-risk prostate cancer. Nerve-sparing radical prostatectomy (NSRP) ...

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study Both the performance ...

Urinary incontinence (UI) after radical prostatectomy is a common and distressing complication for men with prostate cancer.

Urologic surgeon Jose M. Flores, MD is lead author of a new study investigating the risk of biochemical recurrence after radical prostatectomy when taking ED drugs. There have been conflicting studies ...